Page 63 - Genentech News Today

The Huntington Study Group together with its wholly-owned clinical research organization, HSG Clinical Research, Inc. (HSGCR), is pleased to announce a...

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has been improving, but at a slower rate than other cancers. Multimodal treatment, including chemotherapy, surgical resection, and radiotherapy, has been under investigation for many years. Because of the anatomical characteristics of the pancreas, more emphasis on treatment selection has been placed on local extension into major vessels. Recently, the development of more effective treatment regimens has opened up...

As 2023 draws to a close, here’s a gift of five golden Federal Circuit patent cases!  These decisions issued by the U.S. Court of Appeals for the Federal Circuit (CAFC) significantly impact patent practitioners in several areas, including patent prosecution, litigation, and inter partes reviews (IPRs).

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.